Tag: Psychedelics

Posted on

Changing our Minds

Psychedelic Sacraments and the New Psychotherapy – Synergistic Press, Spring 2017

Changing Our Minds is an experiential tour through a social, spiritual and scientific revolution that is redefining our culture’s often confusing relationship with psychoactive substances. Veteran journalist Don Lattin chronicles the inspiring stories of pioneering neuroscientists, psychotherapists, spiritual leaders and ordinary people seeking to lead healthier lives by combining psychedelic drugs, psychotherapy, and the wise use of ancient plant medicines.

Read more about this book, and what Some Leading Lights Are Saying About the New Book on the website of the Author/Journalist

Posted on

Exhibition – The Botanical Mind: Art, Mysticism and The Cosmic Tree

The Botanical Mind: Art, Mysticism and The Cosmic Tree was originally conceived as a trans-generational group exhibition, but has been postponed. In the meantime, we have launched this complimentary online programme of new artist commissions, podcasts, films, texts, images and audio, expanding on and enriching the ideas and issues informing the show over at www.botanicalmind.online.

Drawing on indigenous traditions from the Amazon rainforest; alternative perspectives on Western scientific rationalism; and new thinking around plant intelligence, philosophy and cultural theory, The Botanical Mind Online investigates the significance of the plant kingdom to human life, consciousness and spirituality across cultures and through time. It positions the plant as both a universal symbol found in almost every civilisation and religion across the globe, and the most fundamental but misunderstood form of life on our planet

Continue reading “Exhibition – The Botanical Mind: Art, Mysticism and The Cosmic Tree”
Posted on

Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat

Abstract

Meditation and psychedelics have played key roles in humankind’s search for self-transcendence and personal change. However, neither their possible synergistic effects, nor related state and trait predictors have been experimentally studied. To elucidate these issues, we administered double-blind the model psychedelic drug psilocybin (315 μg/kg PO) or placebo to meditators (n = 39) during a 5-day mindfulness group retreat.

Continue reading “Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat”